• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有双尾部分的碳酸酐酶抑制剂,以匹配碳酸酐酶活性位点的疏水和亲水部分。

Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site.

作者信息

Tanpure Rajendra P, Ren Bin, Peat Thomas S, Bornaghi Laurent F, Vullo Daniela, Supuran Claudiu T, Poulsen Sally-Ann

机构信息

Eskitis Institute for Drug Discovery, Griffith University , Nathan, Queensland 4111, Australia.

出版信息

J Med Chem. 2015 Feb 12;58(3):1494-501. doi: 10.1021/jm501798g. Epub 2015 Jan 27.

DOI:10.1021/jm501798g
PMID:25581127
Abstract

We present a new approach to carbonic anhydrase II (CA II) inhibitor design that enables close interrogation of the regions of the CA active site where there is the greatest variability in amino acid residues among the different CA isozymes. By appending dual tail groups onto the par excellence CA inhibitor acetazolamide, compounds that may interact with the distinct hydrophobic and hydrophilic halves of the CA II active site were prepared. The dual-tail combinations selected included (i) two hydrophobic moieties, (ii) two hydrophilic moieties, and (iii) one hydrophobic and one hydrophilic moiety. The CA enzyme inhibition profile as well as the protein X-ray crystal structure of compound 3, comprising one hydrophobic and one hydrophilic tail moiety, in complex with CA II is described. This novel dual-tail approach has provided an enhanced opportunity to more fully exploit interactions with the CA active site by enabling these molecules to interact with the distinct halves of the active site. In addition to the dual-tail compounds, a corresponding set of single-tail derivatives was synthesized, enabling a comparative analysis of the single-tail versus dual-tail compound CA inhibition profile.

摘要

我们提出了一种设计碳酸酐酶II(CA II)抑制剂的新方法,该方法能够深入研究CA活性位点中不同CA同工酶氨基酸残基差异最大的区域。通过在堪称典范的CA抑制剂乙酰唑胺上连接双尾基团,制备了可能与CA II活性位点不同疏水和亲水部分相互作用的化合物。所选择的双尾组合包括:(i)两个疏水部分,(ii)两个亲水部分,以及(iii)一个疏水部分和一个亲水部分。描述了包含一个疏水尾部分和一个亲水尾部分的化合物3与CA II复合物的CA酶抑制谱以及蛋白质X射线晶体结构。这种新颖的双尾方法提供了一个更好的机会,通过使这些分子与活性位点的不同部分相互作用,更充分地利用与CA活性位点的相互作用。除了双尾化合物外,还合成了相应的单尾衍生物,从而能够对单尾和双尾化合物的CA抑制谱进行比较分析。

相似文献

1
Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site.具有双尾部分的碳酸酐酶抑制剂,以匹配碳酸酐酶活性位点的疏水和亲水部分。
J Med Chem. 2015 Feb 12;58(3):1494-501. doi: 10.1021/jm501798g. Epub 2015 Jan 27.
2
Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site.通过同时匹配活性位点的疏水部分和亲水部分来发现新型碳酸酐酶IX抑制剂的双尾方法。
Eur J Med Chem. 2017 May 26;132:1-10. doi: 10.1016/j.ejmech.2017.03.023. Epub 2017 Mar 16.
3
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.碳酸酐酶抑制剂:与结构相关的环氧化酶II“选择性”抑制剂塞来昔布相比,伐地考昔与人同工型II的不同活性位点区域结合。
Bioorg Med Chem Lett. 2006 Jan 15;16(2):437-42. doi: 10.1016/j.bmcl.2005.09.040. Epub 2005 Nov 14.
4
Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.含支链烷基酰胺部分的抗惊厥 4-氨基苯磺酰胺衍生物:人碳酸酐酶同工型 I、II、VII 和 XIV 的 X 射线晶体学和抑制研究。
J Med Chem. 2011 Jun 9;54(11):3977-81. doi: 10.1021/jm200209n. Epub 2011 May 9.
5
Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes.基于噻唑烷的α-碳酸酐酶同工酶抑制剂的动力学和计算机模拟分析。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):370-4. doi: 10.3109/14756366.2012.732071. Epub 2012 Nov 23.
6
Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.硅藻δ-碳酸酐酶的磺胺抑制研究。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):275-9. doi: 10.1016/j.bmcl.2013.11.021. Epub 2013 Nov 20.
7
Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols.碳酸酐酶抑制剂:用酚类抑制新的膜相关同工型XV。
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3593-6. doi: 10.1016/j.bmcl.2008.04.077. Epub 2008 May 4.
8
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.碳酸酐酶抑制剂。结核分枝杆菌Rv3588c中最具活性的β-碳酸酐酶的特性及抑制研究。
Bioorg Med Chem Lett. 2009 Dec 1;19(23):6649-54. doi: 10.1016/j.bmcl.2009.10.009. Epub 2009 Oct 7.
9
Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.不同带有噻吩基乙酰胺基部分的磺胺类抑制剂的构象变异性归因于在细胞质人碳酸酐酶同工酶的活性部位的不同结合。
Bioorg Med Chem. 2011 Jun 15;19(12):3732-8. doi: 10.1016/j.bmc.2011.05.006. Epub 2011 May 10.
10
Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.利用亲水性和疏水性结合部位设计碳酸酐酶抑制剂。
Expert Opin Drug Discov. 2013 Jul;8(7):793-810. doi: 10.1517/17460441.2013.795145. Epub 2013 Apr 30.

引用本文的文献

1
Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity.含有双三唑部分的新型苯磺酰胺,具有选择性碳酸酐酶抑制作用和抗癌活性。
RSC Med Chem. 2024 Oct 4;16(1):324-45. doi: 10.1039/d4md00617h.
2
Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.以磺酰胺为骨架的 7-芳基/杂芳基三唑并嘧啶的设计、合成及对人碳酸酐酶 II、IX 和 XII 的选择性抑制作用的研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2270180. doi: 10.1080/14756366.2023.2270180. Epub 2023 Oct 18.
3
Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.
五元杂环磺酰胺类碳酸酐酶抑制剂。
Molecules. 2023 Apr 4;28(7):3220. doi: 10.3390/molecules28073220.
4
Pyrazole-sulfonamide scaffold featuring dual-tail strategy as apoptosis inducers in colon cancer.具有双重靶向策略的吡唑-磺胺骨架作为结肠癌凋亡诱导剂。
Sci Rep. 2023 Apr 8;13(1):5782. doi: 10.1038/s41598-023-32820-0.
5
MM/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4.MM/GBSA 预测碳酸酐酶抑制剂的相对结合亲和力:原子电荷的影响及与 Autodock4 的比较。
J Comput Aided Mol Des. 2023 Apr;37(4):167-182. doi: 10.1007/s10822-023-00499-0. Epub 2023 Mar 17.
6
Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII.基于苯并噻唑的 SLC-0111 类似物的设计与合成:作为新型癌症相关碳酸酐rase 同工酶 IX 和 XII 的抑制剂。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2635-2643. doi: 10.1080/14756366.2022.2124409.
7
New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling.新型磺胺甲恶唑衍生物作为选择性碳酸酐酶IX和XII抑制剂:设计、合成、细胞毒性活性及分子模拟
Pharmaceuticals (Basel). 2022 Sep 10;15(9):1134. doi: 10.3390/ph15091134.
8
Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.碳酸酐酶XII抑制作用可克服P-糖蛋白介导的耐药性:一种潜在的癌症新联合治疗方法。
Cancer Drug Resist. 2021 Jun 19;4(2):343-355. doi: 10.20517/cdr.2020.110. eCollection 2021.
9
Gram scale production of 1-azido-β-d-glucose enzyme catalysis for the synthesis of 1,2,3-triazole-glucosides.克级规模生产1-叠氮基-β-D-葡萄糖用于酶催化合成1,2,3-三唑-葡萄糖苷。
RSC Adv. 2019 Feb 20;9(11):6211-6220. doi: 10.1039/c9ra00736a. eCollection 2019 Feb 18.
10
The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.三尾策略作为一种提高磺胺类抑制剂对肿瘤相关碳酸酐酶 IX 和 XII 作用选择性的新策略。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):930-939. doi: 10.1080/14756366.2022.2053526.